Do you provide care for someone with Alzheimer’s disease?

Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: University of California, San Francisco
Locations:
Neurosciences Clinical Research Unit: Sandler Neurosciences Center, Suite 130, 675 Nelson Rising Lane, San Francisco

San Francisco VA Medical Center: 4150 Clement St, San Francisco
Lead Doctor: Dr. Linda Chao
IRB Committee: This study has been reviewed and approved by UCSF Institutional Review Board Committee

Background

Photobiomodulation (PBM) describes the use of near-infrared light (which is not visible to the naked eye) to heal and protect tissue that has either been injured, is degenerating, or else is at risk of dying.

Research suggests that the light delivered during PBM enhances the body’s ability to store and use energy and increase blood flow, which triggers the body’s natural healing processes. Researchers at the University of California are conducting this study to determine if PBM administered through the scalp and skull and through the nose can help improve cognitive function and behavioral symptoms in people with Alzheimer’s disease (AD).

This study seeks men and women who have been diagnosed with Alzheimer’s Disease and have a study partner. Participants are required to attend 2 study visits at the research site over a 4.5 months period and will be compensated $200 for participating in this study.

Why Participate?

  • You may experience an improvement in Alzheimer’s Disease symptoms.
  • You will receive up to $200 for participating in this study.
  • You will be helping to advance Alzheimer’s Disease medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Men and women aged 50+  who have been diagnosed with Alzheimer’s Disease
  • Have a study partner (this can be a family member or friend)
  • Able to attend 2 study visits at each of the research sites (in San Francisco) over approximately 4.5 months.

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial